Explore more publications!
Vatican Health Times
Got News to Share?

Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 10, 2025

24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
December 10, 2025

24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business

Indeterminate GlobeNewswire
SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium
December 10, 2025

SCIENTURE and BlinkRx Announce Strategic Collaboration to Expand Patient Access to Arbli™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

Indeterminate GlobeNewswire
Accrete Health Partners Launches Partnership with Atalan to Co-develop Groundbreaking Patient Experience Intelligence Module
December 10, 2025

Accrete Health Partners Launches Partnership with Atalan to Co-develop Groundbreaking Patient Experience Intelligence Module

Indeterminate GlobeNewswire
Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis
December 10, 2025

Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis

Indeterminate GlobeNewswire
NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
December 10, 2025

NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma

Indeterminate GlobeNewswire
PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them
December 10, 2025

PetMeds Announces Holiday Collection: Wellness-Focused Gifts for Pets and the People Who Love Them

Indeterminate GlobeNewswire
DARE to PLAY™ Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility
December 10, 2025

DARE to PLAY™ Sildenafil Cream Now Available for Pre-Order by Prescription: First Evidence-Based Topical Arousal Cream for Women Begins Commercial Rollout in Select States via 503B Outsourcing Facility

Indeterminate GlobeNewswire
Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease
December 10, 2025

Barinthus Bio Announces Update on Phase 1 AVALON Clinical Trial of VTP-1000 for the Treatment of Celiac Disease

Indeterminate GlobeNewswire
Guardian Recovery – Princeton Detox & Recovery Center Introduces Residential Inpatient Treatment, Creating a Complete Recovery Journey for New Jersey Residents
December 10, 2025

Guardian Recovery – Princeton Detox & Recovery Center Introduces Residential Inpatient Treatment, Creating a Complete Recovery Journey for New Jersey Residents

Indeterminate GlobeNewswire
Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants
December 10, 2025

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire
Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America
December 10, 2025

Avance Clinical Launches Diversity in STEM Scholarships Across Australia and North America

Indeterminate GlobeNewswire
BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025
December 10, 2025

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025

Indeterminate GlobeNewswire
Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors
December 10, 2025

Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its Anti-Tumor Activity in Advanced Solid Tumors

Indeterminate GlobeNewswire
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
December 10, 2025

ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk

Indeterminate GlobeNewswire
Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray
December 10, 2025

Kane Biotech Receives Health Canada Approval for revyve® Antimicrobial Wound Gel Spray

Indeterminate GlobeNewswire
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
December 10, 2025

Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration

Indeterminate GlobeNewswire
Microbix Launches New Products to Support H3N2 Flu Testing
December 10, 2025

Microbix Launches New Products to Support H3N2 Flu Testing

Indeterminate GlobeNewswire
PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets
December 10, 2025

PsiThera Unveiled with Newly Appointed CEO and $47.5 Million Series A to Advance Oral Medicines for Validated I&I Targets

Indeterminate GlobeNewswire
BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
December 10, 2025

BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference

Indeterminate GlobeNewswire
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions